Sign in
COCP Stock Price, Chart, Stats & News
Cocrystal Pharma, Inc.
Save
Cocrystal Pharma, Inc. (COCP) does not currently pay a dividend.
16.13M
Market cap
–
Current P/E
–
Forward P/E
COCP chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -92.58% |
ROE | -129.69% |
D/E | 0.21x |
Interest coverage ratio | – |
COCP valuation
P/E | – |
P/S | – |
P/B | 1.48x |
P/CF | -1.15x |
P/FCF | -1.08x |
P/OCF | -1.15x |
PEG | -0.05x |
EV multiple | -1.73x |
About
Cocrystal Pharma, Inc. (COCP) is a biotechnology firm dedicated to researching and advancing antiviral treatments for severe and/or persistent viral illnesses. The company leverages structure-based technologies to create new antiviral medications, primarily focusing on infections caused by the hepatitis C virus (HCV), influenza, coronaviruses, and noroviruses. Its current pipeline includes CC-31244, a non-nucleoside polymerase inhibitor for HCV, which has successfully completed Phase IIa clinical trials.
Similar securities
Based on sector and market capitalization
Report issue